Global RNA Analysis And Transcriptomics Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global RNA Analysis And Transcriptomics Market Research Report 2024
Transcriptomics and RNA analysis refers to the study of the transcriptome or the complete set of RNA transcripts which are produced by the genome under specific circumstances or in a specific cell.
According to MRAResearch’s new survey, global RNA Analysis And Transcriptomics market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole RNA Analysis And Transcriptomics market research.
Key companies engaged in the RNA Analysis And Transcriptomics industry include Affymetrix Inc.(Thermo Fisher Scientific), Agilent Technologies, Inc., Bio-Rad Laboratories, GE Healthcare Systems(GE), Illumina, Inc., Qiagen N.V., F. Hoffmann-La Roche Ltd., Sigma-Aldrich(Merck KGaA) and Fluidigm Corporation, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of RNA Analysis And Transcriptomics were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole RNA Analysis And Transcriptomics market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global RNA Analysis And Transcriptomics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Affymetrix Inc.(Thermo Fisher Scientific)
Agilent Technologies, Inc.
Bio-Rad Laboratories
GE Healthcare Systems(GE)
Illumina, Inc.
Qiagen N.V.
F. Hoffmann-La Roche Ltd.
Sigma-Aldrich(Merck KGaA)
Fluidigm Corporation
Danaher Corporation
Acobiom
Lexogen GmbH
Promega Corporation
Segment by Type
Microarrays
Polymerase Chain Reaction
Sequencing Technologies
RNAI Gene Silencing
Academic Research Institutes
Pharmaceutical Companies
Hospitals and Diagnostic Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The RNA Analysis And Transcriptomics report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global RNA Analysis And Transcriptomics market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole RNA Analysis And Transcriptomics market research.
Key companies engaged in the RNA Analysis And Transcriptomics industry include Affymetrix Inc.(Thermo Fisher Scientific), Agilent Technologies, Inc., Bio-Rad Laboratories, GE Healthcare Systems(GE), Illumina, Inc., Qiagen N.V., F. Hoffmann-La Roche Ltd., Sigma-Aldrich(Merck KGaA) and Fluidigm Corporation, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of RNA Analysis And Transcriptomics were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole RNA Analysis And Transcriptomics market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global RNA Analysis And Transcriptomics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Affymetrix Inc.(Thermo Fisher Scientific)
Agilent Technologies, Inc.
Bio-Rad Laboratories
GE Healthcare Systems(GE)
Illumina, Inc.
Qiagen N.V.
F. Hoffmann-La Roche Ltd.
Sigma-Aldrich(Merck KGaA)
Fluidigm Corporation
Danaher Corporation
Acobiom
Lexogen GmbH
Promega Corporation
Segment by Type
Microarrays
Polymerase Chain Reaction
Sequencing Technologies
RNAI Gene Silencing
Segment by Application
Academic Research Institutes
Pharmaceutical Companies
Hospitals and Diagnostic Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The RNA Analysis And Transcriptomics report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source